![Agnete Brunsvik Fredriksen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Agnete Brunsvik Fredriksen
Fondateur chez
NYKODE THERAPEUTICS
Fortune : 22 268 $ au 31/05/2026
Profil
Agnete Brunsvik Fredriksen is the founder of Nykode Therapeutics ASA, established in 2006, serving as Chief Scientific Officer since 2024.
Current jobs include Independent Non-Executive Director at Molecular Partners AG since 2021 and Director at Viginti AS.
Former jobs include Director-Life Science at the University of Oslo, Researcher at Medinnova AS, and Researcher at Affitech A. Education history includes graduate and doctorate degrees from the University of Oslo, with the doctorate conferred in 2007.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MOLECULAR PARTNERS AG 0,01 % | 31/12/2025 | 5 541 ( 0,01 % ) | 22 268 $ | 31/05/2026 |
Postes actifs de Agnete Brunsvik Fredriksen
| Sociétés | Poste | Début |
|---|---|---|
| NYKODE THERAPEUTICS | Fondateur | 22/11/2006 |
| MOLECULAR PARTNERS AG | Directeur/Membre du Conseil | 21/04/2021 |
Viginti AS | Directeur/Membre du Conseil | - |
Anciens postes connus de Agnete Brunsvik Fredriksen
| Sociétés | Poste | Fin |
|---|---|---|
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Corporate Officer/Principal | - |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Medinnova AS
 Medinnova AS Investment ManagersFinance Medinnova's investment strategy focuses on developing commercial projects in the areas of biomedicine and health care. They work closely with entrepreneurs and public health care employers to develop ideas, evaluate viability of novel inventions, secure intellectual rights for a patent or protection, assist with product development, prepare business plans, and support applications for public funding. The firm is an active investment partner for the establishment of new firms. They provide access to their network of industry expertise, work cohesively with the public policy system, and negotiate with investors and licensees in addition to following-up with licensees. | Corporate Officer/Principal | - |
Formation de Agnete Brunsvik Fredriksen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Medinnova AS
Medinnova AS Investment ManagersFinance Medinnova's investment strategy focuses on developing commercial projects in the areas of biomedicine and health care. They work closely with entrepreneurs and public health care employers to develop ideas, evaluate viability of novel inventions, secure intellectual rights for a patent or protection, assist with product development, prepare business plans, and support applications for public funding. The firm is an active investment partner for the establishment of new firms. They provide access to their network of industry expertise, work cohesively with the public policy system, and negotiate with investors and licensees in addition to following-up with licensees. | Finance |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Health Technology |
Viginti AS |
